Immune cells and cytokines mediating fibrodysplasia ossificans progressiva
Immune cells and cytokines mediating fibrodysplasia ossificans progressiva
批准号:
8871583
负责人:
Daniel S Perrien
金额:
$20.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2017-03-31
关键词:
AcuteAddressAreaAsphyxiaCCRCell CommunicationCellsCessation of lifeChildhoodChondrocytesClinical TrialsContusionsCyclophosphamideDataDevelopmentDiagnostic radiologic examinationDichloromethylene DiphosphonateDirect Lytic FactorsDiseaseDoseEndotheliumEtanerceptFlareFundingGenesGlucocorticoidsHeterotopic OssificationHistologicHistologyImmobilizationImmuneImmune systemIncidenceInfiltrationInflammationInflammatoryInjection of therapeutic agentInjuryJointsLaboratoriesLeadLesionLiposomesMediatingMediator of activation proteinMusMuscleOsteoblastsOsteogenesisPainPatientsPoint MutationProtocols documentationRecombinantsResearch PersonnelRoleSignal TransductionSiteSkeletal MuscleSkeletal muscle injurySourceSystemic infectionTNF geneTestingTherapeuticTimeTissuesToxinTumor Necrosis Factor-alphabasebonebone morphogenetic protein receptor type Icell typecytokinein vivoinhibitor/antagonistinjuredmacrophagemast cellmicroCTmonocytemouse modelmutantpreventprogressive myositis ossificanspublic health relevance
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Fibrodysplasia ossificans progressiva (FOP) is am untreatable rare congenital disease that results heterotopic ossification (HO) in skeletal muscle leading to immobilization, extreme pain, and eventual death. FOP patients carry an activating single point mutation in one copy of the Acvr1 gene that encodes the bone morphogenetic protein (BMP) Type I receptor, Alk2. Despite widespread expression of mutant Alk2 in numerous tissues the formation of HO lesions is not continuous. Rather, HO appears in distinct sporadic "flares" associated with systemic infections or muscle contusions. Hence, clinicians and researchers have long suspected that HO flares are initiated by inflammation and/or immune cells. Using mouse models of FOP, this laboratory and others have shown that increasing inflammation enhances HO, while high-dose glucocorticoids suppress HO. Unfortunately, glucocorticoids are not clinically effective and little is known about the mechanisms by which inflammation or the immune system trigger HO. TNFa is the most highly expressed cytokine at sites of inflammation, while macrophages are the most abundant immune cells in sites of skeletal muscle damage. Interestingly, both TNFa and macrophages have been shown to enhance endochondral bone formation in certain settings, suggesting possible roles in FOP. This proposal will address the overall hypothesis that macrophages and endogenous expression of TNFa are critical mediators of heterotopic ossification in FOP. Aim 1 will determine the role of endogenous TNFa and Aim 2 will determine the role of macrophages in the initiation and development of HO in a mouse model of FOP. The results of these studies hold to potential to identify new targets that could lead to treatments to prevent or reduce HO in this deadly disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10434101
-
项目类别:
-
资助金额:$41.94万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10150273
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10249238
-
项目类别:
-
资助金额:$42.39万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10168215
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10407678
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10616939
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
vivaCT80 - in vivo small animal microCT
-
批准号:8639867
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2014
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8667309
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8774183
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8442139
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Novel ultrahigh resolution microCT imaging system
-
批准号:7794779
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2010
-
负责人:Daniel S Perrien
-
依托单位:
海外基金